| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.2M | — | -15.0% |
| R&D Expense | $24.6M | — | -9.1% |
| SG&A Expense | $9.3M | — | +0.0% |
| Operating Income | -$27.8M | — | +4.7% |
| Income Tax | $0 | — | — |
| Net Income | -$25.1M | — | +4.5% |
| EPS (Basic) | -$0.20 | — | +45.9% |
| EPS (Diluted) | -$0.20 | — | +45.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $61.3M | -17.9% | +19.5% |
| Accounts Receivable | $2.9M | +20.1% | -64.1% |
| Current Assets | $245.4M | -4.9% | +5.5% |
| Total Assets | $328.9M | -8.4% | +2.9% |
| Current Liabilities | $27.2M | -17.5% | -33.2% |
| Total Liabilities | $94.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$29.9M | — | +10.0% |
| Capital Expenditures | $64K | — | — |
| Investing Cash Flow | $16.2M | — | -44.5% |
| Financing Cash Flow | $462K | — | +1104.3% |
| Free Cash Flow | -$30.0M | — | +9.8% |
| -23.9% |
| Stockholders' Equity | $234.2M | -8.7% | +20.0% |